Literature DB >> 12878547

In vitro activities of florfenicol against bovine and porcine respiratory tract pathogens.

Saskia Priebe1, Stefan Schwarz.   

Abstract

Florfenicol in vitro activities for a total of 756 bacterial isolates from respiratory tract infections of cattle and swine were comparatively investigated by the agar diffusion method and the microdilution broth method. Florfenicol showed high in vitro activity against Pasteurella multocida, Mannheimia haemolytica, Actinobacillus pleuropneumoniae, and Streptococcus suis, with all of the isolates inhibited by </=2 micro g of florfenicol per ml.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12878547      PMCID： PMC166079          DOI： 10.1128/AAC.47.8.2703-2705.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  10 in total

1.  [In vitro activity of 12 antibiotics used in veterinary medicine against Mannheimia haemolytica and Pasteurella multocida isolated from calves in the Netherlands].

Authors:  D J Mevius; E G Hartman
Journal:  Tijdschr Diergeneeskd       Date:  2000-03-01

2.  [Resistance pattern of bovine Pasteurella].

Authors:  S Hörmansdorfer; J Bauer
Journal:  Berl Munch Tierarztl Wochenschr       Date:  1996-05       Impact factor: 0.328

3.  Sequence analysis of the inducible chloramphenicol resistance determinant in the Tn1696 integron suggests regulation by translational attenuation.

Authors:  H W Stokes; R M Hall
Journal:  Plasmid       Date:  1991-07       Impact factor: 3.466

4.  Plasmid-mediated florfenicol resistance encoded by the floR gene in Escherichia coli isolated from cattle.

Authors:  A Cloeckaert; S Baucheron; G Flaujac; S Schwarz; C Kehrenberg; J L Martel; E Chaslus-Dancla
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

5.  Standardization of broth microdilution and disk diffusion susceptibility tests for Actinobacillus pleuropneumoniae and Haemophilus somnus: quality control standards for ceftiofur, enrofloxacin, florfenicol, gentamicin, penicillin, tetracycline, tilmicosin, and trimethoprim-sulfamethoxazole.

Authors:  P F McDermott; A L Barry; R N Jones; G E Stein; C Thornsberry; C C Wu; R D Walker
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

6.  Identification of a plasmid-borne chloramphenicol-florfenicol resistance gene in Staphylococcus sciuri.

Authors:  S Schwarz; C Werckenthin; C Kehrenberg
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

7.  Comparative in vitro activity of 16 antimicrobial agents against Actinobacillus pleuropneumoniae.

Authors:  H Yoshimura; M Takagi; M Ishimura; Y S Endoh
Journal:  Vet Res Commun       Date:  2002-01       Impact factor: 2.459

8.  Antimicrobial susceptibility of Streptococcus suis isolated from swine in France and from humans in different countries between 1996 and 2000.

Authors:  J Marie; H Morvan; F Berthelot-Hérault; P Sanders; I Kempf; A V Gautier-Bouchardon; E Jouy; M Kobisch
Journal:  J Antimicrob Chemother       Date:  2002-08       Impact factor: 5.790

9.  [Resistance of bovine and porcine Pasteurella to florfenicol and other antibiotics].

Authors:  S Hörmansdorfer; J Bauer
Journal:  Berl Munch Tierarztl Wochenschr       Date:  1998 Nov-Dec       Impact factor: 0.328

10.  In vitro antibacterial activity of florfenicol against Actinobacillus pleuropneumoniae.

Authors:  Y Ueda; I Suenaga
Journal:  J Vet Med Sci       Date:  1995-04       Impact factor: 1.267
  10 in total
  9 in total

1.  Antimicrobial susceptibility of Bordetella bronchiseptica isolates from porcine respiratory tract infections.

Authors:  Kristina Kadlec; Corinna Kehrenberg; Jürgen Wallmann; Stefan Schwarz
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

2.  Tn6674 Is a Novel Enterococcal optrA-Carrying Multiresistance Transposon of the Tn554 Family.

Authors:  Dexi Li; Xing-Yun Li; Stefan Schwarz; Mengyan Yang; Su-Mei Zhang; Wenbo Hao; Xiang-Dang Du
Journal:  Antimicrob Agents Chemother       Date:  2019-08-23       Impact factor: 5.191

3.  Florfenicol pharmacokinetics in healthy adult alpacas after subcutaneous and intramuscular injection.

Authors:  K Holmes; D Bedenice; M G Papich
Journal:  J Vet Pharmacol Ther       Date:  2011-07-08       Impact factor: 1.786

4.  Distribution of florfenicol resistance genes fexA and cfr among chloramphenicol-resistant Staphylococcus isolates.

Authors:  Corinna Kehrenberg; Stefan Schwarz
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

5.  Antimicrobial Susceptibility of Bordetella bronchiseptica Isolates from Swine and Companion Animals and Detection of Resistance Genes.

Authors:  Sandra Prüller; Ulrike Rensch; Diana Meemken; Heike Kaspar; Peter A Kopp; Günter Klein; Corinna Kehrenberg
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

6.  Characterisation of a mobilisable plasmid conferring florfenicol and chloramphenicol resistance in Actinobacillus pleuropneumoniae.

Authors:  Janine T Bossé; Yanwen Li; Tom G Atherton; Stephanie Walker; Susanna M Williamson; Jon Rogers; Roy R Chaudhuri; Lucy A Weinert; Matthew T G Holden; Duncan J Maskell; Alexander W Tucker; Brendan W Wren; Andrew N Rycroft; Paul R Langford
Journal:  Vet Microbiol       Date:  2015-05-28       Impact factor: 3.293

7.  Influence of three coccidiostats on the pharmacokinetics of florfenicol in rabbits.

Authors:  Chun Liu; Sheng-Jie Wang; Qian Zhang; Yi-Xiang Shao
Journal:  Exp Anim       Date:  2014-10-16

8.  Antibiotic susceptibility testing of Mycoplasma hyopneumoniae field isolates from Central Europe for fifteen antibiotics by microbroth dilution method.

Authors:  Orsolya Felde; Zsuzsa Kreizinger; Kinga Mária Sulyok; Veronika Hrivnák; Krisztián Kiss; Ákos Jerzsele; Imre Biksi; Miklós Gyuranecz
Journal:  PLoS One       Date:  2018-12-11       Impact factor: 3.240

9.  In vitro and in vivo Synergistic Effects of Florfenicol and Thiamphenicol in Combination Against Swine Actinobacillus pleuropneumoniae and Pasteurella multocida.

Authors:  Porjai Rattanapanadda; Hung-Chih Kuo; Thomas W Vickroy; Chi-Hsuan Sung; Tirawat Rairat; Tsai-Lu Lin; Sze-Yu Yeh; Chi-Chung Chou
Journal:  Front Microbiol       Date:  2019-10-30       Impact factor: 5.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.